These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus. Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736 [TBL] [Abstract][Full Text] [Related]
24. Chronic blepharitis like picture in patients with Discoid lupus erythematosis - Case series. Jisha K; Rajesh PS; Kurien G; Sathish G; Vijayamma N Nepal J Ophthalmol; 2017 Jul; 9(18):175-179. PubMed ID: 29634708 [TBL] [Abstract][Full Text] [Related]
25. Palpebral involvement as a presenting and sole manifestation of discoid lupus erythematosus. Yaghoobi R; Feily A; Behrooz B; Yaghoobi E; Mokhtarzadeh S ScientificWorldJournal; 2010 Nov; 10():2130-1. PubMed ID: 21057726 [TBL] [Abstract][Full Text] [Related]
26. Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea. Oh EH; Kim EJ; Ro YS; Ko JY J Dermatol; 2018 Apr; 45(4):436-443. PubMed ID: 29423919 [TBL] [Abstract][Full Text] [Related]
27. Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry. Drenkard C; Parker S; Aspey LD; Gordon C; Helmick CG; Bao G; Lim SS Arthritis Care Res (Hoboken); 2019 Jan; 71(1):95-103. PubMed ID: 29669194 [TBL] [Abstract][Full Text] [Related]
28. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study. Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857 [TBL] [Abstract][Full Text] [Related]
29. Discoid lupus erythematosus presenting as unilateral blepharitis. Au L Ophthalmic Plast Reconstr Surg; 2006; 22(3):218-9. PubMed ID: 16714936 [TBL] [Abstract][Full Text] [Related]
33. Concurrence of lupus erythematosus and dermatitis herpetiformis. A report of nine cases. Thomas JR; Su WP Arch Dermatol; 1983 Sep; 119(9):740-5. PubMed ID: 6614961 [TBL] [Abstract][Full Text] [Related]
34. Study of cutaneous lupus erythematosus by immunohistochemical methods. Pohle EL; Tuffanelli DL Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670 [No Abstract] [Full Text] [Related]
35. Clinical significance of discoid lesions in systemic lupus erythematosus (SLE) with particular reference to male patients with SLE. Hamaguchi T; Hitaka Y; Takeuchi R; Uchida I J Dermatol; 1978 Aug; 5(4):167-72. PubMed ID: 361781 [No Abstract] [Full Text] [Related]
36. Coexistent psoriasis and lupus erythematosus: what's happening? Hu CH; O'Connell BM; Farber EM Cutis; 1985 Dec; 36(6):449-50. PubMed ID: 4075836 [No Abstract] [Full Text] [Related]
37. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Cardinali C; Caproni M; Fabbri P Clin Exp Rheumatol; 1999; 17(4):427-32. PubMed ID: 10464552 [TBL] [Abstract][Full Text] [Related]
39. Drug-induced lupus: an update on its dermatologic aspects. Marzano AV; Vezzoli P; Crosti C Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393 [TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study. Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]